Phillips Recall CPAP Machines – Potential carcinogenic particles raise concerns. See our article HERE X

FDA Alerts

FDA Warnings About HPP Risks Still Insufficient, Critics Say

The U.S. Food and Drug Administration (FDA) updated the label for the iron replacement medication, Injectafer, in February 2020 to include...

Learn More Address

Zantac Recalled Due to Risk of Cancer Contamination

The online analytical pharmacy, Valisure, advised the U.S. Food and Drug Administration (FDA) of the presence of a cancer-causing chemical...

Learn More Address

FDA Warns of Risk Related to Stryker’s STAR Ankle Replacement

The U.S. Food and Drug Administration (FDA) issued a warning  on March 15, 2021, advising patients and medical providers regarding...

Learn More Address

FDA Warns Penumbra to Recall JET 7 Catheters, Device Failure

On December 15, the U.S. Food and Drug Administration (FDA) issued an Urgent Letter to Health Care Providers advising users...

Learn More Address

What to do if you have taken Zantac/Ranitidine

Picking something up from the drug store to treat something as simple as heartburn typically would not seem like a...

Learn More Address

Numerous Plaintiffs File Zantac Lawsuits

The FDA recommended discontinuing Zantac use in September 2019 and officially recalled the drug in April 2020. Since the recall, multiple...

Learn More Address

Companies Voluntarily Recall Metformin Due to Cancer Risk

Please Note: This article is intended for educational purposes only. CSS Firm is not currently accepting Metformin claims at this...

Learn More Address

Lawsuits Being Filed Regarding Acetaminophen Use Linked to SJS, TEN

Atlanta injury law firm, Childers, Schlueter, & Smith, LLC, filed a lawsuit against Bayer in 2016 alleging that a number...

Learn More Address

Drug Makers Voluntarily Recall Diabetes Drugs Linked to Cancer

The U.S. Food and Drug Administration (FDA) recently ordered five drug manufacturers to recall their brands of metformin, a type...

Learn More Address

FDA Issues Warnings Regarding Xeljanz (tofacitinib)

On July 26, the U.S. Food and Drug Administration (FDA) approved new warnings of an increased chance of blood clots...

Learn More Address